Nencki Institute of Experimental Biology PAS

Become a part of the Nencki Institute of Experimental Biology PAS ❗ Join the most innovative biological research center in Poland! 👇 #nencki #biology #institute

Ponad 200 naukowców zarejestrowanych na spotkanie informacyjne, a 85 do samego końca (a trwało 1,5h). W sumie 48 zgłoszeń z 27 uczelni i instytutów z całego kraju, czyli 48 pomysłów na to, jak przeobrażać wyniki badań naukowych, które są na wczesnym etapie w zastosowania medyczne. Byłoby więcej, ale jak się wysyła wnioski na ostatnią chwilę to czasem przychodzą po terminie 😉 I to wszystko zorganizowaliśmy w dwa miesiące. Czy ktoś miał obawy, że naukowcy nie są zainteresowani zastosowaniami? 🙂 Potraktujmy to nasze doświadczenie jako dowód na to, że naukowcy chcą, ale nie dajemy im tego, czego potrzebują - uwagi na początku projektu naukowego, dostępu do perspektywy rynkowej w celu weryfikacji hipotez, wsparcia w zarządzaniu całym procesem i elastyczności w finansowaniu eksperymentów. Bo w trakcie badań wychodzą rzeczy, których żaden naukowiec nie jest w stanie przewidzieć i wpisać we wniosek grantowy. I chyba o tym w naszym kraju zapomnieliśmy 😉 Dziękujemy wszystkim, którzy dzielili się informacją o SPARK, a szczególnie ''pro science' communications agency 🙂

𝐃𝐫 𝐡𝐚𝐛. Kinga Kamieniarz-Gdula (The Adam Mickiewicz University, Poznan) will give the next 𝘕𝘦𝘯𝘤𝘬𝘪 𝘐𝘯𝘴𝘵𝘪𝘵𝘶𝘵𝘦 𝘚𝘦𝘮𝘪𝘯𝘢𝘳. 🤩 🔸Join us for a lecture entitled: "𝙐𝙣𝙘𝙤𝙪𝙥𝙡𝙞𝙣𝙜 𝙤𝙛 𝙩𝙧𝙖𝙣𝙨𝙘𝙧𝙞𝙥𝙩𝙞𝙤𝙣 𝙩𝙚𝙧𝙢𝙞𝙣𝙖𝙩𝙞𝙤𝙣 𝙖𝙣𝙙 𝙥𝙧𝙚 𝙢𝙍𝙉𝘼 3’ 𝙚𝙣𝙙 𝙥𝙧𝙤𝙘𝙚𝙨𝙨𝙞𝙣𝙜 𝙙𝙪𝙧𝙞𝙣𝙜 𝙘𝙖𝙣𝙘𝙚𝙧 𝙥𝙧𝙤𝙜𝙧𝙚𝙨𝙨𝙞𝙤𝙣” 📅 10.04.2025 o 15:00 🔹Abstract ➡️ https://lnkd.in/dyzeZaZR

📢 Grant from the National Centre for Research and Development for 𝐝𝐫 Katarzyna Kolczyńska-Matysiak ❗ 🔹 Congratulations on receiving funding in the LIDER call for the project: "𝙋𝙆𝘿2 𝙞𝙣𝙝𝙞𝙗𝙞𝙩𝙤𝙧𝙨 𝙖𝙨 𝙖 𝙩𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙛𝙤𝙧 𝙝𝙮𝙥𝙚𝙧𝙡𝙞𝙥𝙞𝙙𝙚𝙢𝙞𝙖 𝙖𝙣𝙙 𝙖𝙩𝙝𝙚𝙧𝙤𝙨𝙘𝙡𝙚𝙧𝙤𝙨𝙞𝙨" 👏👏👏

📢 We are #hiring! The Nencki Institute of Experimental Biology PAS is seeking a candidate for the position of: 𝐏𝐨𝐬𝐭𝐝𝐨𝐜𝐭𝐨𝐫𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫 𝐚𝐭 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐨𝐟 𝐍𝐞𝐮𝐫𝐨𝐧𝐚𝐥 𝐏𝐥𝐚𝐬𝐭𝐢𝐜𝐢𝐭𝐲 🔹We seek a postdoctoral researcher to tackle a project evolving around enhancing/inhibiting synaptic plasticity processes in the central amygdala to modify appetitive and aversive learning. 🔸Number of available positions: 1 🔸Place of work: Laboratory of Neuronal Plasticity 🔸Researcher career profiles (R1-R4): R2/R3 🔸Field of science: neuroscience 🔸Type of recruitment: Opus NCN grant 🔹𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬: ▪ Prior experience in mouse behavioral tests and analysis. ▪ Strong interest in neuroscience research and exceptional motivation for scientific research (demonstrated via publications, references of the candidate’s thesis tutor and mentors). ▪ Doctoral degree obtained not earlier than 7 years before the year of employment in the project. The period of 7 years may be extended by the duration specified in the NCN regulations. ▪ Fluency in English (written and spoken). 🔹𝐒𝐜𝐨𝐩𝐞 𝐨𝐟 𝐰𝐨𝐫𝐤: ▪ Optogenetic stimulation in vivo ▪ Electrophysiological recordings on acute brain slices 🔹𝐄𝐦𝐩𝐥𝐨𝐲𝐦𝐞𝐧𝐭 𝐜𝐨𝐧𝐝𝐢𝐭𝐢𝐨𝐧𝐬: ▪ full-time fixed-term employment contract ▪ salary: ca 9.700 PLN (gross) per month ▪ employment period: 3 years ▪ the date of the project start: June 2025 🔹𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐝𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧: We plan to use pharmacological and optogenetic approaches to modify brain activity. Thus, an experience in mouse behavioral tests and analysis is a must. A background in optogenetics, electrophysiology, and programming will be considered very advantageous. 🔹𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐝 𝐝𝐨𝐜𝐮𝐦𝐞𝐧𝐭𝐬: ▪ CV ▪ Motivation letter ▪ Two reference letters ▪ Statement by the candidate that he/she will not receive remuneration from other projects funded by the National Science Centre. ▪ Declaration that the candidate will not take up other jobs during the period of employment in the project. 🚨 Applications should be sent to postdoc@nencki.edu.pl with note: „Beroun Lab” till 𝐀𝐩𝐫𝐢𝐥 𝟐𝟎𝐭𝐡 𝟐𝟎𝟐𝟓 Contact information ➡️ a.beroun@nencki.edu.pl Link to website ➡️ https://lnkd.in/da3Tbcj5 Full job offer ➡ https://lnkd.in/dzCmHd-j

Join us for a 𝐒𝐏𝐀𝐑𝐊 𝐄𝐮𝐫𝐨𝐩𝐞 𝐖𝐞𝐛𝐢𝐧𝐚𝐫, which will cover the latest regulatory guidelines, challenges, and best practices for developing and approving cell and gene therapies ❗ 🔹 Title: "𝙍𝙚𝙜𝙪𝙡𝙖𝙩𝙤𝙧𝙮 𝙘𝙤𝙣𝙨𝙞𝙙𝙚𝙧𝙖𝙩𝙞𝙤𝙣𝙨 𝙤𝙛 𝘾&𝙂 𝙩𝙝𝙚𝙧𝙖𝙥𝙞𝙚𝙨" 📅 𝟐𝐧𝐝 𝐀𝐩𝐫𝐢𝐥 𝟐𝟎𝟐𝟓 | 𝟒 – 𝟓 𝐩𝐦 (𝐂𝐄𝐒𝐓) | 🔸 Suzanne Einmahl, 𝐏𝐡.𝐃. 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬, will share her expertise in regulatory affairs and offer practical insights on transitioning from fundamental to translational research. She will also explain why implementing a regulatory strategy early helps optimize drug development. With over 23 years of experience, Suzanne has contributed to the development of more than 60 medicinal products, including cell and gene therapies. Please register by April 1st (today) ⬇️ https://lnkd.in/dncstrFM ✨ The webinar will be hosted by SPARK Poland.

International experts in neuro-oncology will soon come to Poland❗ ⌛ Until the end of March, it is possible to register at a lower price for the 𝐁𝐫𝐚𝐢𝐧 𝐓𝐮𝐦𝐨𝐫𝐬 𝟐𝟎𝟐𝟓: 𝐅𝐫𝐨𝐦 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐭𝐨 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐜𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞, organized by the Nencki Institute of Experimental Biology at the Polish Academy of Sciences in collaboration with the Foundation of Clinical and Experimental Oncology and University of Warsaw. 📅 𝐉𝐮𝐧𝐞 𝟏𝟔-𝟏𝟖, 𝟐𝟎𝟐𝟓. 🔹 Our multidisciplinary program will focus on the latest advancements in tumor immunology and immunotherapy, complemented by insights from allied disciplines, equipping attendees with innovative tools and techniques to apply in their own work. 🌎 Renowned international speakers will present their newest findings, and the best oral and poster presentations will be recognized with awards. 👥 The conference will provide an excellent opportunity for all participants to present and discuss their research, expand their professional networks, and exchange ideas. 🚨 𝐎𝐧𝐥𝐲 𝐮𝐧𝐭𝐢𝐥 𝟑𝟏.𝟎𝟑 𝐭𝐡𝐞𝐫𝐞 𝐚𝐫𝐞 𝐥𝐨𝐰𝐞𝐫 𝐫𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐩𝐫𝐢𝐜𝐞𝐬! Register now ➡️  https://lnkd.in/dd5dY7sn The full program can be found here ⬇️ https://lnkd.in/dHh3fjzP

𝐃𝐫 Dimitris Xirodimas (Cell Biology Research Centre of Montpellier, CNRS, Montpellier, France) gave yesterday's 𝘕𝘦𝘯𝘤𝘬𝘪 𝘐𝘯𝘴𝘵𝘪𝘵𝘶𝘵𝘦 𝘚𝘦𝘮𝘪𝘯𝘢𝘳 🤩 🔸The title of the lecture was: "𝙋𝙧𝙤𝙩𝙚𝙤𝙨𝙩𝙖𝙨𝙞𝙨 𝘾𝙤𝙣𝙩𝙧𝙤𝙡: 𝙐𝙗𝙞𝙦𝙪𝙞𝙩𝙞𝙣 𝙖𝙣𝙙 𝙐𝙗𝙞𝙦𝙪𝙞𝙩𝙞𝙣-𝙡𝙞𝙠𝙚 𝙢𝙤𝙙𝙞𝙛𝙞𝙘𝙖𝙩𝙞𝙤𝙣𝙨 𝙞𝙣 𝙥𝙧𝙤𝙩𝙚𝙞𝙣 𝙢𝙞𝙨𝙛𝙤𝙡𝙙𝙞𝙣𝙜 𝙖𝙣𝙙 𝙖𝙜𝙜𝙧𝙚𝙜𝙖𝙩𝙞𝙤𝙣” Thank you to dr 𝐗𝐢𝐫𝐨𝐝𝐢𝐦𝐚𝐬 for giving the speech and to all the listeners for an active participation❗️

📢 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐍𝐞𝐧𝐜𝐤𝐢 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐢𝐧 𝐄𝐁𝐑𝐀𝐈𝐍𝐒 𝐎𝐩𝐞𝐧 𝐂𝐚𝐥𝐥 ✨ Four new projects, selected as part of the EBRAINS Open Call, will enrich the platform with extensive datasets and new brain atlases, fully reflecting the FAIR (Findability, Accessibility, Interoperability, and Reusability) principles for data sharing. One of the winners is Marmoset@EBRAINS run by 𝐝𝐫. 𝐏𝐢𝐨𝐭𝐫 𝐌𝐚𝐣𝐤𝐚 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐨𝐟 𝐍𝐞𝐮𝐫𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬, 𝐨𝐟 𝐭𝐡𝐞 𝐍𝐞𝐧𝐜𝐤𝐢𝐞 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞. Congratulations! 👏 This is the first Polish project to establish a close collaboration with EBRAINS. 🔹  As a result, the EBRAINS platform will gain a new marmoset (Callithrix jacchus) cerebral cortex atlas, based on a morphological brain template of 20 young adult individuals. Furthermore, comprehensive maps of neuronal distribution and data from 143 experiments on cortical connections will be made available. 🔸These new projects will significantly contribute to the continued development of EBRAINS as a key platform in the field of neuroscience. More details➡ https://lnkd.in/eiy_9yKW

📢 𝐏𝐫𝐨𝐟. Daniel Wojcik elected Vice-Chairman Of The 𝐄𝐁𝐑𝐀𝐈𝐍𝐒-𝐏𝐋 Council❗ 🔸On March 17th, on the eve of the European Brain Health Day, the first meeting of the EBRAINS-PL Consortium Governing Board took place. During the meeting, the Presidium of the Board was elected for a three-year term, including:  ▪️𝐜𝐡𝐚𝐢𝐫𝐦𝐚𝐧 - Prof. Michal Nowicki from the Poznan Medical University ▪️𝐯𝐢𝐜𝐞-𝐜𝐡𝐚𝐢𝐫𝐬 - Prof. Daniel Wójcik from the Nencki Institute and Prof. Monika Adamczyk Sowa from the Silesian Medical University in Katowice. 🔹The Consortium's coordinator is Dr. Cezary Mazurek from the Poznan Supercomputing and Networking Center. ➡ 𝐄𝐁𝐑𝐀𝐈𝐍𝐒-𝐏𝐋 is an initiative bringing together Polish scientists, clinicians, and experts in modern information technologies who are jointly developing an advanced digital research infrastructure for brain sciences. The Consortium's activities align with global efforts to better understand brain function and work for better understanding of neurodegenerative diseases